{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["antidepressant", "depression", "herbal", "medicinal plants", "treatment"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36902200", "DateCompleted": {"Year": "2023", "Month": "03", "Day": "14"}, "DateRevised": {"Year": "2023", "Month": "03", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "03", "Day": "01"}], "Language": ["eng"], "ELocationID": ["4772", "10.3390/ijms24054772"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "24", "Issue": "5", "PubDate": {"Year": "2023", "Month": "Mar", "Day": "01"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Depression and Its Phytopharmacotherapy-A Narrative Review.", "Abstract": {"AbstractText": ["Depression is a mental health disorder that develops as a result of complex psycho-neuro-immuno-endocrinological disturbances. This disease presents with mood disturbances, persistent sadness, loss of interest and impaired cognition, which causes distress to the patient and significantly affects the ability to function and have a satisfying family, social and professional life. Depression requires comprehensive management, including pharmacological treatment. Because pharmacotherapy of depression is a long-term process associated with the risk of numerous adverse drug effects, much attention is paid to alternative therapy methods, including phytopharmacotherapy, especially in treating mild or moderate depression. Preclinical studies and previous clinical studies confirm the antidepressant activity of active compounds in plants, such as St. John's wort, saffron crocus, lemon balm and lavender, or less known in European ethnopharmacology, roseroot, ginkgo, Korean ginseng, borage, brahmi, mimosa tree and magnolia bark. The active compounds in these plants exert antidepressive effects in similar mechanisms to those found in synthetic antidepressants. The description of phytopharmacodynamics includes inhibiting monoamine reuptake and monoamine oxidase activity and complex, agonistic or antagonistic effects on multiple central nervous system (CNS) receptors. Moreover, it is noteworthy that the anti-inflammatory effect is also important to the antidepressant activity of the plants mentioned above in light of the hypothesis that immunological disorders of the CNS are a significant pathogenetic factor of depression. This narrative review results from a traditional, non-systematic literature review. It briefly discusses the pathophysiology, symptomatology and treatment of depression, with a particular focus on the role of phytopharmacology in its treatment. It provides the mechanisms of action revealed in experimental studies of active ingredients isolated from herbal antidepressants and presents the results of selected clinical studies confirming their antidepressant effectiveness."]}, "AuthorList": [{"Identifier": ["0000-0001-5049-0026"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Pharmacology, Wroclaw Medical University, 50-556 Wroclaw, Poland."}], "LastName": "Dobrek", "ForeName": "Lukasz", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Pharmacology, Wroclaw Medical University, 50-556 Wroclaw, Poland."}], "LastName": "G\u0142owacka", "ForeName": "Krystyna", "Initials": "K"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antidepressive Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Depression"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antidepressive Agents"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Depressive Disorder"}, {"QualifierName": [], "DescriptorName": "Hypericum"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Clack S., Ward T. The classification and explanation of depression. Behav. Chang. 2019;36:41\u201355. doi: 10.1017/bec.2019.4.", "ArticleIdList": ["10.1017/bec.2019.4"]}, {"Citation": "World Health Organisation  ICD-11 for Mortality and Morbidity Statistics. Version: 02/2022.  [(accessed on 20 November 2022)].  Available online:  https://icd.who.int/browse11/l-m/en."}, {"Citation": "Pardhe H.A., Nagalakshmi N.C., Hariprasad M.G., Chourasia P.K., Nandini S. A review: Medicinal plants with antidepressant properties. Indian J. Neurosci. 2020;6:1\u20135. doi: 10.18231/j.ijn.2020.001.", "ArticleIdList": ["10.18231/j.ijn.2020.001"]}, {"Citation": "Martins J., Brijesh S. Phytochemistry and pharmacology of anti-depressant medicinal plants: A review. Biomed. Pharmacother. 2018;104:343\u2013365. doi: 10.1016/j.biopha.2018.05.044.", "ArticleIdList": ["10.1016/j.biopha.2018.05.044", "29778018"]}, {"Citation": "World Health Organisation  Depression.  [(accessed on 20 November 2022)].  Available online:  https://www.who.int/news-room/fact-sheets/detail/depression."}, {"Citation": "Torre J., Vilagut G., Ronaldson A., Serrano-Blanco A., Mart\u00edn V., Peters M., Valderas J., Dregan A., Alonso J. Prevalence and variability of current depressive disorder in 27 European countries: A population-based study. Lancet Public Health. 2021;6:e729\u2013e738. doi: 10.1016/S2468-2667(21)00047-5.", "ArticleIdList": ["10.1016/S2468-2667(21)00047-5", "PMC8460452", "33961802"]}, {"Citation": "Ga\u0142ecki P., Samochowiec J., Miku\u0142owska M., Szulc A. Treatment-Resistant Depression in Poland\u2014Epidemiology and Treatment. J. Clin. Med. 2022;11:480. doi: 10.3390/jcm11030480.", "ArticleIdList": ["10.3390/jcm11030480", "PMC8837165", "35159935"]}, {"Citation": "Centers for Disease Control and Prevention  National Center for Health Statistics. Anxiety and Depression.  [(accessed on 18 January 2023)]; Available online:  https://www.cdc.gov/nchs/covid19/pulse/mental-health.htm."}, {"Citation": "Chiu E. Epidemiology of depression in the Asia Pacific region. Australas Psychiatry. 2004;12:S4\u2013S10. doi: 10.1080/j.1039-8562.2004.02099.x-1.", "ArticleIdList": ["10.1080/j.1039-8562.2004.02099.x-1", "15715830"]}, {"Citation": "Ogbo F.A., Mathsyaraja S., Koti R.K., Perz J., Page A. The burden of depressive disorders in South Asia, 1990\u20132016: Findings from the global burden of disease study. BMC Psychiatry. 2018;18:333. doi: 10.1186/s12888-018-1918-1.", "ArticleIdList": ["10.1186/s12888-018-1918-1", "PMC6192293", "30326863"]}, {"Citation": "Pan American Health Organization and World Health Organization  World Mental Health Day: Depression, the Most Common Mental Disorder.  [(accessed on 18 January 2023)].  Available online:  https://www3.paho.org/hq/index.php?option=com_content&view=article&id=7305:2012-dia-mundial-salud-mental-depresion-trastorno-mental-mas-frecuente&Itemid=0&lang=en#gsc.tab=0."}, {"Citation": "Cuadros D.F., Tomita A., Vandormael A., Slotow R., Burns J.K., Tanser F. Spatial structure of depression in South Africa: A longitudinal panel survey of a nationally representative sample of households. Sci. Rep. 2019;9:979. doi: 10.1038/s41598-018-37791-1.", "ArticleIdList": ["10.1038/s41598-018-37791-1", "PMC6354020", "30700798"]}, {"Citation": "Bedaso A., Mekonnen N., Duko B. Estimate of the prevalence of depression among older people in Africa: A systematic review and meta-analysis. Aging Ment. Health. 2022;26:1095\u20131105. doi: 10.1080/13607863.2021.1932740.", "ArticleIdList": ["10.1080/13607863.2021.1932740", "34129417"]}, {"Citation": "Australian Institute of Health and Welfare  Prevalence and Impact of Mental Illness.  [(accessed on 18 January 2023)]; Available online:  https://www.aihw.gov.au/mental-health/overview/mental-illness#mental-disorder."}, {"Citation": "Sarris J., Panossian A., Schweitzer I., Stough C., Scholey A. Herbal medicine for depression, anxiety and insomnia: A review of psychopharmacology and clinical evidence. Eur. Neuropsychopharmacol. 2011;21:841\u2013860. doi: 10.1016/j.euroneuro.2011.04.002.", "ArticleIdList": ["10.1016/j.euroneuro.2011.04.002", "21601431"]}, {"Citation": "Bernaras E., Jaureguizar J., Garaigordobil M. Child and Adolescent Depression: A Review of theories, evaluation instruments, prevention programs, and treatments. Front. Psychol. 2019;10:543. doi: 10.3389/fpsyg.2019.00543.", "ArticleIdList": ["10.3389/fpsyg.2019.00543", "PMC6435492", "30949092"]}, {"Citation": "Deverteuil R.L., Lehmann H.E. Therapeutic trial of iproniazid (marsilid) in depressed and apathetic patients. Can. Med. Assoc. J. 1958;78:131\u2013133.", "ArticleIdList": ["PMC1829550", "13489643"]}, {"Citation": "Kuhn R. The treatment of depressive states with G 22355 (imipramine hydrochloride) Am. J. Psychiatry. 1958;115:459\u2013464. doi: 10.1176/ajp.115.5.459.", "ArticleIdList": ["10.1176/ajp.115.5.459", "13583250"]}, {"Citation": "Schildkraut J.J., Kety S.S. Biogenic amines and emotion. Science. 1967;156:21\u201337. doi: 10.1126/science.156.3771.21.", "ArticleIdList": ["10.1126/science.156.3771.21", "5335690"]}, {"Citation": "Qin D.D., Rizak J., Feng X.L., Yang S.C., L\u00fc L.B., Pan L., Yin Y., Hu X.T. Prolonged secretion of cortisol as a possible mechanism underlying stress and depressive behaviour. Sci. Rep. 2016;6:30187. doi: 10.1038/srep30187.", "ArticleIdList": ["10.1038/srep30187", "PMC4957121", "27443987"]}, {"Citation": "Herbert J. Cortisol and depression: Three questions for psychiatry. Psychol. Med. 2013;43:449\u2013469. doi: 10.1017/S0033291712000955.", "ArticleIdList": ["10.1017/S0033291712000955", "22564216"]}, {"Citation": "Mikulska J., Juszczyk G., Gawro\u0144ska-Grzywacz M., Herbet M. HPA Axis in the pathomechanism of depression and schizophrenia: New therapeutic strategies based on its participation. Brain Sci. 2021;11:1298. doi: 10.3390/brainsci11101298.", "ArticleIdList": ["10.3390/brainsci11101298", "PMC8533829", "34679364"]}, {"Citation": "Jesulola E., Micalos P., Baguley I.J. Understanding the Pathophysiology of Depression: From Monoamines to the Neurogenesis Hypothesis Model\u2014Are We There Yet? Behav. Brain Res. 2018;341:79\u201390.", "ArticleIdList": ["29284108"]}, {"Citation": "Lee C.H., Giuliani F. The Role of Inflammation in Depression and Fatigue. Front. Immunol. 2019;10:1696. doi: 10.3389/fimmu.2019.01696.", "ArticleIdList": ["10.3389/fimmu.2019.01696", "PMC6658985", "31379879"]}, {"Citation": "Wohleb E.S., Franklin T., Iwata M., Duman R.S. Integrating Neuroimmune Systems in the Neurobiology of Depression. Nat. Rev. Neurosci. 2016;17:497\u2013511. doi: 10.1038/nrn.2016.69.", "ArticleIdList": ["10.1038/nrn.2016.69", "27277867"]}, {"Citation": "Beurel E., Toups M., Nemeroff C.B. The bidirectional relationship of depression and inflammation: Double trouble. Neuron. 2020;107:234\u2013256. doi: 10.1016/j.neuron.2020.06.002.", "ArticleIdList": ["10.1016/j.neuron.2020.06.002", "PMC7381373", "32553197"]}, {"Citation": "Wi\u0119d\u0142ocha M., Marcinowicz P., Krupa R., Janoska-Ja\u017adzik M., Janus M., D\u0119bowska W., Mosio\u0142ek A., Waszkiewicz N., Szulc A. Effect of antidepressant treatment on peripheral inflammation markers\u2014A meta-analysis. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2018;80:217\u2013226. doi: 10.1016/j.pnpbp.2017.04.026.", "ArticleIdList": ["10.1016/j.pnpbp.2017.04.026", "28445690"]}, {"Citation": "Savitz J. Role of kynurenine metabolism pathway activation in major depressive disorders. Curr. Top. Behav. Neurosci. 2017;31:249\u2013267.", "ArticleIdList": ["27221627"]}, {"Citation": "Berk M., Williams L.J., Jacka F.N., O\u2019Neil A., Pasco J.A., Moylan S., Allen N.B., Stuart A.L., Hayley A.C., Byrne M.L., et al. So depression is an inflammatory disease, but where does the inflammation come from? BMC Med. 2013;11:200. doi: 10.1186/1741-7015-11-200.", "ArticleIdList": ["10.1186/1741-7015-11-200", "PMC3846682", "24228900"]}, {"Citation": "Salim S. Oxidative stress and the central nervous system. J. Pharmacol. Exp. Ther. 2017;360:201\u2013205. doi: 10.1124/jpet.116.237503.", "ArticleIdList": ["10.1124/jpet.116.237503", "PMC5193071", "27754930"]}, {"Citation": "Jimenez-Fernandez S., Gurpegui M., Diaz-Atienza F., Perez-Costillas L., Gerstenberg M., Correll C.U. Oxidative stress and antioxidant parameters in patients with major depressive disorder compared to healthy controls before and after antidepressant treatment: Results from a meta-analysis. J. Clin. Psychiatry. 2015;76:1658\u20131667. doi: 10.4088/JCP.14r09179.", "ArticleIdList": ["10.4088/JCP.14r09179", "26579881"]}, {"Citation": "Guilliams T.G., Edwards L. Chronic stress and the HPA axis: Clinical assessment and therapeutic considerations. Standard. 2010;9:1\u201312."}, {"Citation": "Carabotti M., Scirocco A., Maselli M.A., Severi C. The Gut-Brain Axis: Interactions between enteric microbiota, central and enteric nervous systems. Ann. Gastroenterol. 2015;28:203\u2013209.", "ArticleIdList": ["PMC4367209", "25830558"]}, {"Citation": "Cryan J.F., O\u2019Riordan K.J., Cowan C.S.M., Sandhu K.V., Bastiaanssen T.F.S., Boehme M., Codagnone M.G., Cussotto S., Fulling C., Golubeva A.V., et al. The Microbiota-Gut-Brain Axis. Physiol. Rev. 2019;99:1877\u20132013. doi: 10.1152/physrev.00018.2018.", "ArticleIdList": ["10.1152/physrev.00018.2018", "31460832"]}, {"Citation": "Liang S., Wu X., Hu X., Wang T., Jin F. Recognizing depression from the microbiota\u2013gut\u2013brain axis. Int. J. Mol. Sci. 2018;19:1592. doi: 10.3390/ijms19061592.", "ArticleIdList": ["10.3390/ijms19061592", "PMC6032096", "29843470"]}, {"Citation": "Alvarez-Mon M.A., G\u00f3mez A.M., Orozco A., Lahera G., Sosa M.D., Diaz D., Auba E., Albillos A., Monserrat J., Alvarez-Mon M. Abnormal distribution and function of circulating monocytes and enhanced bacterial translocation in major depressive disorder. Front. Psychiatry. 2019;10:812. doi: 10.3389/fpsyt.2019.00812.", "ArticleIdList": ["10.3389/fpsyt.2019.00812", "PMC6873610", "31803077"]}, {"Citation": "Strandwitz P. Neurotransmitter modulation by the gut microbiota. Brain Res. 2018;1693:128. doi: 10.1016/j.brainres.2018.03.015.", "ArticleIdList": ["10.1016/j.brainres.2018.03.015", "PMC6005194", "29903615"]}, {"Citation": "Bromberger J.T., Schott L.L., Kravitz H.M., Sowers M., Avis N.E., Gold E.B., Randolph J.F., Jr., Matthews K.A. Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: Results from the Study of Women\u2019s Health Across the Nation (SWAN) Arch. Gen. Psychiatry. 2010;67:598\u2013607. doi: 10.1001/archgenpsychiatry.2010.55.", "ArticleIdList": ["10.1001/archgenpsychiatry.2010.55", "PMC3129620", "20530009"]}, {"Citation": "Soares C.N., Zitek B. Reproductive hormone sensitivity and risk for depression across the female life cycle: A continuum of vulnerability? J. Psychiatry Neurosci. 2008;33:331\u2013343.", "ArticleIdList": ["PMC2440795", "18592034"]}, {"Citation": "Sullivan P.F., Neale M.C., Kendler K.S. Genetic epidemiology of major depression: Review and meta-analysis. Am. J. Psychiatry. 2000;157:1552\u20131562. doi: 10.1176/appi.ajp.157.10.1552.", "ArticleIdList": ["10.1176/appi.ajp.157.10.1552", "11007705"]}, {"Citation": "Menke A., Klengel T., Binder E.B. Epigenetics, depression and antidepressant treatment. Curr. Pharm. Des. 2012;18:5879\u20135889. doi: 10.2174/138161212803523590.", "ArticleIdList": ["10.2174/138161212803523590", "22681167"]}, {"Citation": "Krishnan V., Nestler E.J. The molecular neurobiology of depression. Nature. 2008;455:894\u2013902. doi: 10.1038/nature07455.", "ArticleIdList": ["10.1038/nature07455", "PMC2721780", "18923511"]}, {"Citation": "Monteggia L.M., Luikart B., Barrot M., Theobold D., Malkovska I., Nef S., Parada L.F., Nestler E.J. Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biol. Psychiatry. 2007;15:187\u2013197. doi: 10.1016/j.biopsych.2006.03.021.", "ArticleIdList": ["10.1016/j.biopsych.2006.03.021", "16697351"]}, {"Citation": "Eisch A.J., Bola\u00f1os C.A., de Wit J., Simonak R.D., Pudiak C.M., Barrot M., Verhaagen J., Nestler E.J. Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: A role in depression. Biol. Psychiatry. 2003;54:994\u20131005. doi: 10.1016/j.biopsych.2003.08.003.", "ArticleIdList": ["10.1016/j.biopsych.2003.08.003", "14625141"]}, {"Citation": "Duman R.S., Voleti B. Signaling pathways underlying the pathophysiology and treatment of depression: Novel mechanisms for rapid-acting agents. Trends Neurosci. 2012;35:47\u201356. doi: 10.1016/j.tins.2011.11.004.", "ArticleIdList": ["10.1016/j.tins.2011.11.004", "PMC3278537", "22217452"]}, {"Citation": "Shadrina M., Bondarenko E.A., Slominsky P.A. Genetics factors in major depression disease. Front. Psychiatry. 2018;9:334. doi: 10.3389/fpsyt.2018.00334.", "ArticleIdList": ["10.3389/fpsyt.2018.00334", "PMC6065213", "30083112"]}, {"Citation": "Lohoff F.W. Overview of the genetics of major depressive disorder. Curr. Psychiatry Rep. 2010;12:539\u2013546. doi: 10.1007/s11920-010-0150-6.", "ArticleIdList": ["10.1007/s11920-010-0150-6", "PMC3077049", "20848240"]}, {"Citation": "Mariani N., Cattane N., Pariante C., Cattaneo A. Gene expression studies in depression development and treatment: An overview of the underlying molecular mechanisms and biological processes to identify biomarkers. Transl. Psychiatry. 2021;11:354. doi: 10.1038/s41398-021-01469-6.", "ArticleIdList": ["10.1038/s41398-021-01469-6", "PMC8187383", "34103475"]}, {"Citation": "Dupont C., Armant D.R., Brenner C.A. Epigenetics: Definition, mechanisms and clinical perspective. Semin. Reprod. Med. 2009;27:351\u2013357. doi: 10.1055/s-0029-1237423.", "ArticleIdList": ["10.1055/s-0029-1237423", "PMC2791696", "19711245"]}, {"Citation": "Al Aboud N.M., Tupper C., Jialal I.  StatPearls. StatPearls Publishing; Treasure Island, FL, USA: 2022.  [(accessed on 22 January 2023)]. Genetics, Epigenetic Mechanism. Available online:  https://www.ncbi.nlm.nih.gov/books/NBK532999/"}, {"Citation": "Penner-Goeke S., Binder E.B. Epigenetics and depression. Dialogues Clin. Neurosci. 2019;21:397\u2013405. doi: 10.31887/DCNS.2019.21.4/ebinder.", "ArticleIdList": ["10.31887/DCNS.2019.21.4/ebinder", "PMC6952745", "31949407"]}, {"Citation": "Czarny P., Bia\u0142ek K., Zi\u00f3\u0142kowska S., Strycharz J., Barszczewska G., Sliwinski T. The importance of epigenetics in diagnostics and treatment of major depressive disorder. J. Pers. Med. 2021;11:167. doi: 10.3390/jpm11030167.", "ArticleIdList": ["10.3390/jpm11030167", "PMC7999864", "33804455"]}, {"Citation": "Blatt S.J. Experiences of Depression: Theoretical, Clinical, and Research Perspectives. American Psychological Association; Worcester, MA, USA: 2004.", "ArticleIdList": ["10.1037/10749-000"]}, {"Citation": "Tonon A.C., Pilz L.K., Markus R.P., Hidalgo M.P., Elisabetsky. E. Melatonin and depression: A translational perspective from animal models to clinical studies. Front. Psychiatry. 2021;12:638981. doi: 10.3389/fpsyt.2021.638981.", "ArticleIdList": ["10.3389/fpsyt.2021.638981", "PMC8060443", "33897495"]}, {"Citation": "Wang Y.Q., Jiang Y.J., Zou M.S., Liu J., Zhao H.Q., Wang Y.H. Antidepressant actions of melatonin and melatonin receptor agonist: Focus on pathophysiology and treatment. Behav. Brain Res. 2022;420:113724. doi: 10.1016/j.bbr.2021.113724.", "ArticleIdList": ["10.1016/j.bbr.2021.113724", "34929236"]}, {"Citation": "Gonz\u00e1lez-D\u00edaz S.N., Arias-Cruz A., Elizondo-Villarreal B., Monge-Ortega O.P. Psychoneuroimmunoendocrinology: Clinical implications. World Allergy Organ. J. 2017;10:19. doi: 10.1186/s40413-017-0151-6.", "ArticleIdList": ["10.1186/s40413-017-0151-6", "PMC5460476", "28616124"]}, {"Citation": "Singh T., Williams K. Atypical depression. Psychiatry. 2006;3:33\u201339.", "ArticleIdList": ["PMC2990566", "21103169"]}, {"Citation": "Munro M., Milne R. Symptoms and causes of depression, and its diagnosis and management. Nurs. Times. 2020;116:18\u201322."}, {"Citation": "Kennedy S.H. Core symptoms of major depressive disorder: Relevance to diagnosis and treatment. Dialogues Clin. Neurosci. 2008;10:271\u2013277. doi: 10.31887/DCNS.2008.10.3/shkennedy.", "ArticleIdList": ["10.31887/DCNS.2008.10.3/shkennedy", "PMC3181882", "18979940"]}, {"Citation": "Bhowmik D., Kumar K.P.S., Srivastava S., Paswan S., Dutta A.S. Depression-symptoms, causes, medications and therapies. Pharma Innov. 2012;1:32\u201345."}, {"Citation": "Kuria M.W., Ndetei D.M., Obot I.S., Khasakhala L.I., Bagaka B.M., Mbugua M.N., Kamau J. The association between alcohol dependence and depression before and after treatment for alcohol dependence. ISRN Psychiatry. 2012;2012:482802. doi: 10.5402/2012/482802.", "ArticleIdList": ["10.5402/2012/482802", "PMC3658562", "23738204"]}, {"Citation": "Timonen M., Liukkonen T. Management of depression in adults. BMJ. 2008;336:435\u2013439. doi: 10.1136/bmj.39478.609097.BE.", "ArticleIdList": ["10.1136/bmj.39478.609097.BE", "PMC2249627", "18292169"]}, {"Citation": "Bleakley S. Review of choice and use of antidepressants. Prog. Neurol. Psychiatry. 2009;13:14\u201320. doi: 10.1002/pnp.107.", "ArticleIdList": ["10.1002/pnp.107"]}, {"Citation": "Faquih A.E., Memon R.I., Hafeez H., Zeshan M., Naveed S. A review of novel antidepressants: A guide for clinicians. Cureus. 2019;11:e4185. doi: 10.7759/cureus.4185.", "ArticleIdList": ["10.7759/cureus.4185", "PMC6504013", "31106085"]}, {"Citation": "Cipriani A., Furukawa T.A., Salanti G., Chaimani A., Atkinson L.Z., Ogawa Y., Leucht S., Ruhe H.G., Turner E.H., Higgins J.P.T., et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: A systematic review and network meta-analysis. Lancet. 2018;391:1357\u20131366. doi: 10.1016/S0140-6736(17)32802-7.", "ArticleIdList": ["10.1016/S0140-6736(17)32802-7", "PMC5889788", "29477251"]}, {"Citation": "Ramic E., Prasko S., Gavran L., Spahic E. Assessment of the antidepressant side effects occurrence in patients treated in primary care. Mater. Sociomed. 2020;32:131\u2013134. doi: 10.5455/msm.2020.32.131-134.", "ArticleIdList": ["10.5455/msm.2020.32.131-134", "PMC7428926", "32843862"]}, {"Citation": "Edinoff A.N., Akuly H.A., Hanna T.A., Ochoa C.O., Patti S.J., Ghaffar Y.A., Kaye A.D., Viswanath O., Urits I., Boyer A.G., et al. Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review. Neurol. Int. 2021;13:387\u2013401. doi: 10.3390/neurolint13030038.", "ArticleIdList": ["10.3390/neurolint13030038", "PMC8395812", "34449705"]}, {"Citation": "Moraczewski J., Aedma K.K.  StatPearls. StatPearls Publishing; Treasure Island, FL, USA: 2022.  [(accessed on 25 January 2023)]. Tricyclic Antidepressants. Available online:  https://www.ncbi.nlm.nih.gov/books/NBK557791."}, {"Citation": "Gautam S., Jain A., Gautam M., Vahia V.N., Grover S. Clinical practice guidelines for the management of depression. Indian J. Psychiatry. 2017;59:S34\u2013S50.", "ArticleIdList": ["PMC5310101", "28216784"]}, {"Citation": "Practice Guideline for the Treatment of Patients with Major Depressive Disorder.  [(accessed on 2 December 2022)].  Available online:  https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/mdd.pdf."}, {"Citation": "Almeida S.S., Zizzi F.B., Cattaneo A., Comandini A., Di Dato G., Lubrano E., Pellicano C., Spallone V., Tongiani S., Torta R. Management and treatment of patients with major depressive disorder and chronic diseases: A multidisciplinary approach. Front. Psychol. 2020;11:542444. doi: 10.3389/fpsyg.2020.542444.", "ArticleIdList": ["10.3389/fpsyg.2020.542444", "PMC7546762", "33101117"]}, {"Citation": "American Psychological Association  Clinical Practice Guideline for the Treatment of Depression across Three Age Cohorts. 2019.  [(accessed on 2 December 2022)].  Available online:  https://www.apa.org/depression-guideline."}, {"Citation": "Samochowiec J., Dudek D., Mazur J.K., Murawiec S., Rymaszewska J., Cuba\u0142a W.J., Heitzman J., Szulc A., Ba\u0142a M., Ga\u0142ecki P. Pharmacological treatment of a depressive episode and recurrent depressive disorder\u2014Guidelines of the Polish Psychiatric Association and the National Consultant for Adult Psychiatry. Psychiatry Pol. 2021;55:235\u2013259. doi: 10.12740/PP/OnlineFirst/132496.", "ArticleIdList": ["10.12740/PP/OnlineFirst/132496", "34365477"]}, {"Citation": "Farah W.H., Alsawas M., Mainou M., Alahdab F., Farah M.H., Ahmed A.T., Mohamed E.A., Almasri J., Gionfriddo M.R., Castaneda-Guarderas A., et al. Non-pharmacological treatment of depression: A systematic review and evidence map. Evid. Based Med. 2016;21:214\u2013221. doi: 10.1136/ebmed-2016-110522.", "ArticleIdList": ["10.1136/ebmed-2016-110522", "27836921"]}, {"Citation": "Gautam M., Tripathi A., Deshmukh D., Gaur M. Cognitive behavioral therapy for depression. Indian J. Psychiatry. 2020;62:S223\u2013S229. doi: 10.4103/psychiatry.IndianJPsychiatry_772_19.", "ArticleIdList": ["10.4103/psychiatry.IndianJPsychiatry_772_19", "PMC7001356", "32055065"]}, {"Citation": "Thurfah J.N., Christine, Bagaskhara P.P., Alfian S.D., Puspitasari I.M. Dietary supplementations and depression. J. Multidiscip. Healthc. 2022;15:1121\u20131141.", "ArticleIdList": ["PMC9123934", "35607362"]}, {"Citation": "Ortega M.A., Fraile-Mart\u00ednez \u00d3., Garc\u00eda-Montero C., Alvarez-Mon M.A., Lahera G., Monserrat J., Llavero-Valero M., Guti\u00e9rrez-Rojas L., Molina R., Rodr\u00edguez-Jimenez R., et al. Biological role of nutrients, food and dietary patterns in the prevention and clinical management of major depressive disorder. Nutrients. 2022;14:3099. doi: 10.3390/nu14153099.", "ArticleIdList": ["10.3390/nu14153099", "PMC9370795", "35956276"]}, {"Citation": "Rizvi S., Khan A.M. Use of transcranial magnetic stimulation for depression. Cureus. 2019;11:e4736. doi: 10.7759/cureus.4736.", "ArticleIdList": ["10.7759/cureus.4736", "PMC6649915", "31355095"]}, {"Citation": "Porter R., Linsley K., Ferrier N. Treatment of severe depression\u2014Non-pharmacological aspects. Adv. Psychiatr. Treat. 2001;7:117\u2013124. doi: 10.1192/apt.7.2.117.", "ArticleIdList": ["10.1192/apt.7.2.117"]}, {"Citation": "Chen J.J., Zhao L.B., Liu Y.Y., Fan S.H., Xie P. Comparative efficacy and acceptability of electroconvulsive therapy versus repetitive transcranial magnetic stimulation for major depression: A systematic review and multiple-treatments meta-analysis. Behav. Brain Res. 2017;320:30\u201336. doi: 10.1016/j.bbr.2016.11.028.", "ArticleIdList": ["10.1016/j.bbr.2016.11.028", "27876667"]}, {"Citation": "Micallef-Trigona B. Comparing the effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in the treatment of depression: A systematic review and meta-analysis. Depress Res. Treat. 2014;2014:135049. doi: 10.1155/2014/135049.", "ArticleIdList": ["10.1155/2014/135049", "PMC4131106", "25143831"]}, {"Citation": "Iacobucci G. NHS prescribed record number of antidepressants last year. BMJ. 2019;364:l1508. doi: 10.1136/bmj.l1508.", "ArticleIdList": ["10.1136/bmj.l1508", "30926584"]}, {"Citation": "Pratt L.A., Brody D.J., Gu Q. Antidepressant use among persons aged 12 and over: United States, 2011\u20132014. CHS Data Brief. 2017;283:1\u20138.", "ArticleIdList": ["29155679"]}, {"Citation": "Reinert M., Fritze D., Nguyen T.  Mental Health America; Alexandria, VA, USA:  [(accessed on 2 December 2022)]. The State of Mental Health in America 2022. Available online:  https://mhanational.org/sites/default/files/2022%20State%20of%20Mental%20Health%20in%20America.pdf."}, {"Citation": "Lewer D., O\u2019Reilly C., Mojtabai R., Evans-Lacko S. Antidepressant use in 27 European countries: Associations with sociodemographic, cultural and economic factors. Br. J. Psychiatry. 2015;207:221\u2013226. doi: 10.1192/bjp.bp.114.156786.", "ArticleIdList": ["10.1192/bjp.bp.114.156786", "26159603"]}, {"Citation": "Sisay T., Wami R. Adverse drug reactions among major depressive disorders: Patterns by age and gender. Heliyon. 2021;7:e08655. doi: 10.1016/j.heliyon.2021.e08655.", "ArticleIdList": ["10.1016/j.heliyon.2021.e08655", "PMC8718962", "35005292"]}, {"Citation": "Degner D., Grohmann R., Kropp S., R\u00fcther E., Bender S., Engel R.R., Schmidt L.G. Severe adverse drug reactions of antidepressants: Results of the German multicenter drug surveillance program AMSP. Pharmacopsychiatry. 2004;37:S39\u2013S45.", "ArticleIdList": ["15052513"]}, {"Citation": "Uher R., Farmer A., Henigsberg N., Rietschel M., Mors O., Maier W., Kozel D., Hauser J., Souery D., Placentino A., et al. Adverse reactions to antidepressants. Br. J. Psychiatry. 2009;195:202\u2013210. doi: 10.1192/bjp.bp.108.061960.", "ArticleIdList": ["10.1192/bjp.bp.108.061960", "19721108"]}, {"Citation": "Jiao Y., Wickett N.J., Ayyampalayam S., Chanderbali A.S., Landherr L., Ralph P.E., Tomsho L.P., Hu Y., Liang H., Soltis P.S., et al. Ancestral polyploidy in seed plants and angiosperms. Nature. 2011;473:97\u2013100. doi: 10.1038/nature09916.", "ArticleIdList": ["10.1038/nature09916", "21478875"]}, {"Citation": "Sahoo S. A review of some medicinal plants used for nervous system. J. Med. Plants Stud. 2018;6:220\u2013224."}, {"Citation": "Ulrich-Merzenich G., Panek D., Zeitler H., Vetter H., Wagner H. Drug development from natural products: Exploiting synergistic effects. Indian J. Exp. Biol. 2010;48:208\u2013219.", "ArticleIdList": ["21046973"]}, {"Citation": "Wagner H., Ulrich-Merzenich G. Synergy research: Approaching a new generation of phytopharmaceuticals. Phytomedicine. 2009;16:97\u2013110. doi: 10.1016/j.phymed.2008.12.018.", "ArticleIdList": ["10.1016/j.phymed.2008.12.018", "19211237"]}, {"Citation": "Wink M. Modes of action of herbal medicines and plant secondary metabolites. Medicines. 2015;2:251\u2013286. doi: 10.3390/medicines2030251.", "ArticleIdList": ["10.3390/medicines2030251", "PMC5456217", "28930211"]}, {"Citation": "Kessler R.C., Soukup J., Davis R.B., Foster D.F., Wilkey S.A., Van Rompay M.I., Eisenberg D.M. The use of complementary and alternative therapies to treat anxiety and depression in the United States. Am. J. Psychiatry. 2001;158:289\u2013294. doi: 10.1176/appi.ajp.158.2.289.", "ArticleIdList": ["10.1176/appi.ajp.158.2.289", "11156813"]}, {"Citation": "Elkins G., Rajab M.H., Marcus J. Complementary and alternative medicine use by psychiatric inpatients. Psychol. Rep. 2005;96:163\u2013166. doi: 10.2466/pr0.96.1.163-166.", "ArticleIdList": ["10.2466/pr0.96.1.163-166", "15825920"]}, {"Citation": "Kumar V. Potential medicinal plants for CNS disorders: An overview. Phytother Res. 2006;20:1023\u20131035. doi: 10.1002/ptr.1970.", "ArticleIdList": ["10.1002/ptr.1970", "16909441"]}, {"Citation": "Peschel W. The use of community herbal monographs to facilitate registrations and authorisations of herbal medicinal products in the European Union 2004\u20132012. J. Ethnopharmacol. 2014;158:471\u2013486. doi: 10.1016/j.jep.2014.07.015.", "ArticleIdList": ["10.1016/j.jep.2014.07.015", "25043780"]}, {"Citation": "Moreira D.L., Teixeira S.S., Monteiro M.H.D., de-Oliveira A.C.A.X., Paumgartten F.J.R. Traditional use and safety of herbal medicines. Rev. Bras. Farmacogn. 2014;24:248\u2013257. doi: 10.1016/j.bjp.2014.03.006.", "ArticleIdList": ["10.1016/j.bjp.2014.03.006"]}, {"Citation": "Papakostas G.I. The efficacy, tolerability, and safety of contemporary antidepressants. J. Clin. Psychiatry. 2010;71:e03. doi: 10.4088/JCP.9058se1c.03gry.", "ArticleIdList": ["10.4088/JCP.9058se1c.03gry", "20371030"]}, {"Citation": "Baldwin D.S., Montgomery S.A., Nil R., Lader M. Discontinuation symptoms in depression and anxiety disorders. Int. J. Neuropsychopharmacol. 2007;10:73\u201384. doi: 10.1017/S1461145705006358.", "ArticleIdList": ["10.1017/S1461145705006358", "16359583"]}, {"Citation": "Wilson E., Lader M. A review of the management of antidepressant discontinuation symptoms. Ther. Adv. Psychopharmacol. 2015;5:357\u2013368. doi: 10.1177/2045125315612334.", "ArticleIdList": ["10.1177/2045125315612334", "PMC4722507", "26834969"]}, {"Citation": "Alvarez-Mon M.A., Ortega M.A., Garc\u00eda-Montero C., Fraile-Martinez O., Monserrat J., Lahera G., Mora F., Rodriguez-Quiroga A., Fernandez-Rojo S., Quintero J., et al. Exploring the role of nutraceuticals in major depressive disorder (MDD): Rationale, state of the art and future prospects. Pharmaceuticals. 2021;14:821. doi: 10.3390/ph14080821.", "ArticleIdList": ["10.3390/ph14080821", "PMC8399392", "34451918"]}, {"Citation": "Wang Y., Su C., Zhang B., Niu Y., Ren R., Zhao X., Yang L., Zhang W., Ma X. Biological activity, hepatotoxicity, and structure-activity relationship of kavalactones and flavokavins, the two main bioactive components in kava (Piper methysticum) Evid. Based Complement. Altern. Med. 2021;2021:6851798. doi: 10.1155/2021/6851798.", "ArticleIdList": ["10.1155/2021/6851798", "PMC8405297", "34471418"]}, {"Citation": "Staines S.S. Herbal medicines: Adverse effects and drug-herbs interactions. J. Malta Coll. Pharm. Pract. 2011;17:38\u201342."}, {"Citation": "Henderson L., Yue Q.Y., Bergquist C., Gerden B., Arlett P. St. John\u2019s wort (Hypericum perforatum): Drug interactions and clinical outcomes. Br. J. Clin. Pharmacol. 2002;54:349\u2013356. doi: 10.1046/j.1365-2125.2002.01683.x.", "ArticleIdList": ["10.1046/j.1365-2125.2002.01683.x", "PMC1874438", "12392581"]}, {"Citation": "Canenguez Benitez J.S., Hernandez T.E., Sundararajan R., Sarwar S., Arriaga A.J., Khan A.T., Matayoshi A., Quintanilla H.A., Kochhar H., Alam M., et al. Advantages and disadvantages of using St. John\u2019s Wort as a treatment for depression. Cureus. 2022;14:e29468. doi: 10.7759/cureus.29468.", "ArticleIdList": ["10.7759/cureus.29468", "PMC9587902", "36299970"]}, {"Citation": "Ekor M. The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety. Front. Pharmacol. 2014;4:177. doi: 10.3389/fphar.2013.00177.", "ArticleIdList": ["10.3389/fphar.2013.00177", "PMC3887317", "24454289"]}, {"Citation": "Hammerness P., Basch E., Ulbricht C., Barrette P., Foppa I., Basch S., Bent S., Boon H., Ernst E. Natural Standard Research Collaboration. St John\u2019s wort: A systematic review of adverse effects and drug interactions for the consultation psychiatrist. Psychosomatics. 2003;44:271\u2013282. doi: 10.1176/appi.psy.44.4.271.", "ArticleIdList": ["10.1176/appi.psy.44.4.271", "12832592"]}, {"Citation": "Joshi K.G., Faubion M.D. Mania and psychosis associated with St. John\u2019s wort and ginseng. Psychiatry. 2005;2:56\u201361.", "ArticleIdList": ["PMC2993537", "21120109"]}, {"Citation": "Nicolussi S., Drewe J., Butterweck V., Zu Schwabedissen H.E.M. Clinical relevance of St. John\u2019s wort drug interactions revisited. Br. J. Pharmacol. 2020;177:1212\u20131226. doi: 10.1111/bph.14936.", "ArticleIdList": ["10.1111/bph.14936", "PMC7056460", "31742659"]}, {"Citation": "Grimstein M., Huang S.M. A regulatory science viewpoint on botanical-drug interactions. J. Food Drug Anal. 2018;26:S12\u2013S25. doi: 10.1016/j.jfda.2018.01.013.", "ArticleIdList": ["10.1016/j.jfda.2018.01.013", "PMC9326881", "29703380"]}, {"Citation": "Moore L.B., Goodwin B., Jones S.A., Wisely G.B., Serabjit-Singh C.J., Willson T.M., Collins J.L., Kliewer S.A. St. John\u2019s wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc. Natl. Acad. Sci. USA. 2000;97:7500\u20137502. doi: 10.1073/pnas.130155097.", "ArticleIdList": ["10.1073/pnas.130155097", "PMC16574", "10852961"]}, {"Citation": "Markowitz J.S., Donovan J.L., DeVane C.L., Taylor R.M., Ruan Y., Wang J.S., Chavin K.D. Effect of St John\u2019s wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. JAMA. 2003;290:1500\u20131504. doi: 10.1001/jama.290.11.1500.", "ArticleIdList": ["10.1001/jama.290.11.1500", "13129991"]}, {"Citation": "Kleemann B., Loos B., Scriba T.J., Lang D., Davids L.M. St. John\u2019s wort (Hypericum perforatum L.) photomedicine: Hypericin-photodynamic therapy induces metastatic melanoma cell death. PLoS ONE. 2014;9:e103762. doi: 10.1371/journal.pone.0103762.", "ArticleIdList": ["10.1371/journal.pone.0103762", "PMC4116257", "25076130"]}, {"Citation": "Vollmer J.J., Rosenson J. Chemistry of St. John\u2019s wort: Hypericin and hyperforin. J. Chem. Educ. 2004;81:1450. doi: 10.1021/ed081p1450.", "ArticleIdList": ["10.1021/ed081p1450"]}, {"Citation": "Moshiri M., Vahabzadeh M., Hosseinzadeh H. Clinical applications of saffron (Crocus sativus) and its constituents: A review. Drug Res. 2015;65:287\u2013295. doi: 10.1055/s-0034-1375681.", "ArticleIdList": ["10.1055/s-0034-1375681", "24848002"]}, {"Citation": "Barnes J. Saffron. J. Prim. Health Care. 2022;14:189\u2013190. doi: 10.1071/HC22067.", "ArticleIdList": ["10.1071/HC22067", "35771700"]}, {"Citation": "Zam W., Quispe C., Sharifi-Rad J., L\u00f3pez M.D., Schoebitz M., Martorell M., Sharopov F., Fokou P.V.T., Mishra A.P., Chandran D., et al. An updated review on the properties of Melissa officinalis L.: Not exclusively anti-anxiety. Front. Biosci. 2022;14:16. doi: 10.31083/j.fbs1402016.", "ArticleIdList": ["10.31083/j.fbs1402016", "35730441"]}, {"Citation": "Block K.I., Gyllenhaal C., Mead M.N. Safety and efficacy of herbal sedatives in cancer care. Integr. Cancer Ther. 2004;3:128\u2013148. doi: 10.1177/1534735404265003.", "ArticleIdList": ["10.1177/1534735404265003", "15165499"]}, {"Citation": "Unger M. Pharmacokinetic drug interactions involving Ginkgo biloba. Drug Metab. Rev. 2013;45:353\u2013385. doi: 10.3109/03602532.2013.815200.", "ArticleIdList": ["10.3109/03602532.2013.815200", "23865865"]}, {"Citation": "Nguyen T., Alzahrani T.  StatPearls. StatPearls Publishing; Treasure Island, FL, USA: 2022.  [(accessed on 23 February 2023)]. Ginkgo Biloba. Available online:  https://www.ncbi.nlm.nih.gov/books/NBK541024/"}, {"Citation": "Sadler C., Charrois T.L., Vohra S. Gingko biloba: Practical management of adverse effects and drug interactions. Canadian Pharm. J. Rev. Pharm. Can. 2006;139:32\u201335. doi: 10.1177/171516350613900508.", "ArticleIdList": ["10.1177/171516350613900508"]}, {"Citation": "Kiefer D., Pantuso T. Panax ginseng. Am. Fam. Phys. 2003;68:1539\u20131542.", "ArticleIdList": ["14596440"]}, {"Citation": "Tao H., Wu X., Cao J., Peng Y., Wang A., Pei J., Xiao J., Wang S., Wang Y. Rhodiola species: A comprehensive review of traditional use, phytochemistry, pharmacology, toxicity, and clinical study. Med. Res. Rev. 2019;39:1779\u20131850. doi: 10.1002/med.21564.", "ArticleIdList": ["10.1002/med.21564", "30652331"]}, {"Citation": "Sarrica A., Kirika N., Romeo M., Salmona M., Diomede L. Safety and toxicology of magnolol and honokiol. Planta Med. 2018;84:1151\u20131164. doi: 10.1055/a-0642-1966.", "ArticleIdList": ["10.1055/a-0642-1966", "29925102"]}, {"Citation": "Sayyah M., Siahpoosh A., Khalili H., Malayeri A., Samaee H. A double-blind, placebo-controlled study of the aqueous extract of Echium amoenum for patients with general anxiety disorder. Iran J. Pharm. Res. 2012;11:697\u2013701.", "ArticleIdList": ["PMC3832167", "24250495"]}, {"Citation": "Peth-Nui T., Wattanathorn J., Muchimapura S., Tong-Un T., Piyavhatkul N., Rangseekajee P., Ingkaninan K., Vittaya-Areekul S. Effects of 12-week Bacopa monnieri consumption on attention, cognitive processing, working memory, and functions of both cholinergic and monoaminergic systems in healthy elderly volunteers. Evid. Based Complement. Alternat. Med. 2012;2012:606424. doi: 10.1155/2012/606424.", "ArticleIdList": ["10.1155/2012/606424", "PMC3537209", "23320031"]}, {"Citation": "Sanaye M.M., Joglekar C.S., Pagare N.P. Mimosa\u2014A brief overview. J. Pharmacogn. Phytochem. 2015;4:182\u2013187."}, {"Citation": "Wang Y.S., Shen C.Y., Jiang J.G. Antidepressant active ingredients from herbs and nutraceuticals used in TCM: Pharmacological mechanisms and prospects for drug discovery. Pharmacol. Res. 2019;150:104520. doi: 10.1016/j.phrs.2019.104520.", "ArticleIdList": ["10.1016/j.phrs.2019.104520", "31706012"]}, {"Citation": "Farahani M.S., Bahramsoltani R., Farzaei M.H., Abdollahi M., Rahimi R. Plant-derived natural medicines for the management of depression: An overview of mechanisms of action. Rev. Neurosci. 2015;26:305\u2013321. doi: 10.1515/revneuro-2014-0058.", "ArticleIdList": ["10.1515/revneuro-2014-0058", "25719303"]}, {"Citation": "Zhang Z., Deng T., Wu M., Zhu A., Zhu G. Botanicals as modulators of depression and mechanisms involved. Chin. Med. 2019;14:24. doi: 10.1186/s13020-019-0246-9.", "ArticleIdList": ["10.1186/s13020-019-0246-9", "PMC6628492", "31338119"]}, {"Citation": "Lundstrom K., Pham H.T., Dinh L.D. Interaction of plant extracts with central nervous system receptors. Medicines. 2017;4:12. doi: 10.3390/medicines4010012.", "ArticleIdList": ["10.3390/medicines4010012", "PMC5597072", "28930228"]}, {"Citation": "Parveen A., Parveen B., Parveen R., Ahmad S. Challenges and guidelines for clinical trial of herbal drugs. J. Pharm. Bioallied Sci. 2015;7:329\u2013333.", "ArticleIdList": ["PMC4678978", "26681895"]}, {"Citation": "Jachak S.M., Saklani A. Challenges and opportunities in drug discovery from plants. Curr. Sci. 2007;92:1251\u20131257."}, {"Citation": "Williams R., M\u00fcnch G., Gyengesi E., Bennett L. Bacopa monnieri (L.) exerts anti-inflammatory effects on cells of the innate immune system in vitro. Food Funct. 2014;5:517\u2013520. doi: 10.1039/C3FO60467E.", "ArticleIdList": ["10.1039/C3FO60467E", "24452710"]}, {"Citation": "Nemetchek M.D., Stierle A.A., Stierle D.B., Lurie D.I. The Ayurvedic plant Bacopa monnieri inhibits inflammatory pathways in the brain. J. Ethnopharmacol. 2017;197:92\u2013100. doi: 10.1016/j.jep.2016.07.073.", "ArticleIdList": ["10.1016/j.jep.2016.07.073", "PMC5269610", "27473605"]}, {"Citation": "Mathur A.S., Verma S.K., Purohit R., Singh S.K., Mathur D., Prasad G.K., Dua V.K. Pharmacological investigation of Bacopa monnieri on the basis of antioxidant, antimicrobial and anti-inflammatory properties. J. Chem. Pharm. Res. 2010;2:191\u2013198."}, {"Citation": "Rai K., Gupta N.S., Dharamdasani L., Nair P., Bodhankar P. Bacopa monnieri: A wonder drug changing fortune of people. IJASBT. 2017;5:127\u2013132. doi: 10.3126/ijasbt.v5i2.16952.", "ArticleIdList": ["10.3126/ijasbt.v5i2.16952"]}, {"Citation": "Bhattacharya S.K., Bhattacharya A., Kumar A., Ghosal S. Antioxidant activity of Bacopa monniera in rat frontal cortex, striatum and hippocampus. Phytother. Res. 2000;14:174\u2013179. doi: 10.1002/(SICI)1099-1573(200005)14:3<174::AID-PTR624>3.0.CO;2-O.", "ArticleIdList": ["10.1002/(SICI)1099-1573(200005)14:3<174::AID-PTR624>3.0.CO;2-O", "10815010"]}, {"Citation": "Jin J., Boersch M., Nagarajan A., Davey A.K., Zunk M. Antioxidant properties and reported ethnomedicinal use of the genus Echium (Boraginaceae) Antioxidants. 2020;9:722. doi: 10.3390/antiox9080722.", "ArticleIdList": ["10.3390/antiox9080722", "PMC7466025", "32784832"]}, {"Citation": "Naseri N., Kalantar K., Amirghofran Z. Anti-inflammatory activity of Echium amoenum extract on macrophages mediated by inhibition of inflammatory mediators and cytokines expression. Res. Pharm. Sci. 2018;13:73\u201381.", "ArticleIdList": ["PMC5772084", "29387114"]}, {"Citation": "Das Noor-E-Tabassum R., Lami M.S., Chakraborty A.J., Mitra S., Tallei T.E., Idroes R., Mohamed A.A., Hossain M.J., Dhama K., Mostafa-Hedeab G., et al. Ginkgo biloba: A treasure of functional phytochemicals with multimedicinal applications. Evid. Based Complement. Alternat. Med. 2022;2022:8288818. doi: 10.1155/2022/8288818.", "ArticleIdList": ["10.1155/2022/8288818", "PMC8901348", "35265150"]}, {"Citation": "Kaur S., Sharma N., Nehru B. Anti-inflammatory effects of Ginkgo biloba extract against trimethyltin-induced hippocampal neuronal injury. Inflammopharmacology. 2018;26:87\u2013104. doi: 10.1007/s10787-017-0396-2.", "ArticleIdList": ["10.1007/s10787-017-0396-2", "28918573"]}, {"Citation": "Gargouri B., Carstensen J., Bhatia H.S., Huell M., Dietz G.P.H., Fiebich B.L. Anti-neuroinflammatory effects of Ginkgo biloba extract EGb761 in LPS-activated primary microglial cells. Phytomedicine. 2018;44:45\u201355. doi: 10.1016/j.phymed.2018.04.009.", "ArticleIdList": ["10.1016/j.phymed.2018.04.009", "29895492"]}, {"Citation": "Li M., Li B., Hou Y., Tian Y., Chen L., Liu S., Zhang N., Dong J. Anti-inflammatory effects of chemical components from Ginkgo biloba L. male flowers on lipopolysaccharide-stimulated RAW264.7 macrophages. Phytother. Res. 2019;33:989\u2013997. doi: 10.1002/ptr.6292.", "ArticleIdList": ["10.1002/ptr.6292", "30693991"]}, {"Citation": "Piazza S., Pacchetti B., Fumagalli M., Bonacina F., Dell\u2019Agli M., Sangiovanni E. Comparison of two Ginkgo biloba L. extracts on oxidative stress and inflammation markers in human endothelial cells. Mediat. Inflamm. 2019;2019:6173893. doi: 10.1155/2019/6173893.", "ArticleIdList": ["10.1155/2019/6173893", "PMC6614955", "31341420"]}, {"Citation": "Barbalho S.M., Direito R., Laurindo L.F., Marton L.T., Guiguer E.L., Goulart R.A., Tofano R.J., Carvalho A.C.A., Flato U.A.P., Tofano V.A.C., et al. Ginkgo biloba in the aging process: A narrative review. Antioxidants. 2022;11:525. doi: 10.3390/antiox11030525.", "ArticleIdList": ["10.3390/antiox11030525", "PMC8944638", "35326176"]}, {"Citation": "An M.Y., Lee S.R., Hwang H.J., Yoon J.G., Lee H.J., Cho J.A. Antioxidant and anti-inflammatory effects of korean black ginseng extract through ER stress pathway. Antioxidants. 2021;10:62. doi: 10.3390/antiox10010062.", "ArticleIdList": ["10.3390/antiox10010062", "PMC7825445", "33419084"]}, {"Citation": "Park J., Cho J.Y. Anti-inflammatory effects of ginsenosides from Panax ginseng and their structural analogs. Afr. J. Biotechnol. 2009;8:3682\u20133690."}, {"Citation": "Pandur E., Balatin\u00e1cz A., Micalizzi G., Mondello L., Horv\u00e1th A., Sipos K., Horv\u00e1th G. Anti-inflammatory effect of lavender (Lavandula angustifolia Mill.) essential oil prepared during different plant phenophases on THP-1 macrophages. BMC Complement. Med. Ther. 2021;21:287. doi: 10.1186/s12906-021-03461-5.", "ArticleIdList": ["10.1186/s12906-021-03461-5", "PMC8611982", "34819075"]}, {"Citation": "Silva G.L., Luft C., Lunardelli A., Amaral R.H., Melo D.A., Donadio M.V., Nunes F.B., de Azambuja M.S., Santana J.C., Moraes C.M., et al. Antioxidant, analgesic and anti-inflammatory effects of lavender essential oil. An. Acad. Bras. Cienc. 2015;87:1397\u20131408. doi: 10.1590/0001-3765201520150056.", "ArticleIdList": ["10.1590/0001-3765201520150056", "26247152"]}, {"Citation": "Cardia G.F., Silva-Filho S.E., Silva E.L., Uchida N.S., Cavalcante H.A., Cassarotti L.L., Salvadego V.E., Spironello R.A., Bersani-Amado C.A., Cuman R.K. Effect of lavender (Lavandula angustifolia) essential oil on acute inflammatory response. Evid. Based Complement. Alternat. Med. 2018;2018:1413940. doi: 10.1155/2018/1413940.", "ArticleIdList": ["10.1155/2018/1413940", "PMC5878871", "29743918"]}, {"Citation": "\u015awi\u0105der K., Startek K., Wijaya C.H. The therapeutic properties of lemon balm (Melissa officinalis L.): Reviewing novel findings and medical indications. J. Appl. Bot. Food Qual. 2019;92:327\u2013335."}, {"Citation": "Draginic N., Andjic M., Jeremic J., Zivkovic V., Kocovic A., Tomovic M., Bozin B., Kladar N., Bolevich S., Jakovljevic V., et al. Anti-inflammatory and antioxidant effects of Melissa officinalis extracts: A comparative study. Iran J. Pharm. Res. 2022;21:e126561. doi: 10.5812/ijpr-126561.", "ArticleIdList": ["10.5812/ijpr-126561", "PMC9420213", "36060902"]}, {"Citation": "Miraj S., Rafieian-Kopaei, Kiani S. Melissa officinalis L: A review study with an antioxidant prospective. J. Evid. Based Complement. Altern. Med. 2017;22:385\u2013394.", "ArticleIdList": ["PMC5871149", "27620926"]}, {"Citation": "Eliaz I. Honokiol research review. A promising extract with multiple applications. Nat. Med. J. 2014.  [(accessed on 27 January 2023)].  Available online:  https://www.naturalmedicinejournal.com/journal/honokiol-research-review."}, {"Citation": "Walker J.M., Maitra A., Walker J., Ehrnhoefer-Ressler M.M., Inui T., Somoza V. Identification of Magnolia officinalis L. bark extract as the most potent anti-inflammatory of four plant extracts. Am. J. Chin. Med. 2013;41:531\u2013544. doi: 10.1142/S0192415X13500389.", "ArticleIdList": ["10.1142/S0192415X13500389", "23711140"]}, {"Citation": "Lee J., Jung E., Park J., Jung K., Lee S., Hong S., Park J., Park E., Kim J., Park S., et al. Anti-inflammatory effects of magnolol and honokiol are mediated through inhibition of the downstream pathway of MEKK-1 in NF-kappaB activation signaling. Planta Med. 2005;71:338\u2013343. doi: 10.1055/s-2005-864100.", "ArticleIdList": ["10.1055/s-2005-864100", "15856410"]}, {"Citation": "Ramachandran C., Wilk B., Melnick S.J., Eliaz I. Synergistic antioxidant and anti-inflammatory effects between modified citrus pectin and honokiol. Evid. Based Complement. Alternat. Med. 2017;2017:8379843. doi: 10.1155/2017/8379843.", "ArticleIdList": ["10.1155/2017/8379843", "PMC5576403", "28900464"]}, {"Citation": "Kokila K., Priyadharshini S.D., Sujatha V. Phytopharmacological properties of Albizia species: A review. Int. J. Pharm. Pharm. Sci. 2013;5:70\u201373."}, {"Citation": "Balkrishna A., Sakshi, Chauhan M., Dabas A., Arya V. A comprehensive insight into the phytochemical, pharmacological potential, and traditional medicinal uses of Albizia lebbeck (L.) Benth. Evid. Based Complement. Alternat. Med. 2022;2022:5359669. doi: 10.1155/2022/5359669.", "ArticleIdList": ["10.1155/2022/5359669", "PMC9050289", "35497931"]}, {"Citation": "Babu N.P., Pandikumar P., Ignacimuthu S. Anti-inflammatory activity of Albizia lebbeck Benth., an ethnomedicinal plant, in acute and chronic animal models of inflammation. J. Ethnopharmacol. 2009;125:356\u2013360. doi: 10.1016/j.jep.2009.02.041.", "ArticleIdList": ["10.1016/j.jep.2009.02.041", "19643557"]}, {"Citation": "Kuum M.G.M., Guemmogne R.J.T., Ndzana M.T.B., Tchadji J.C., Lissom A., Dimo T. Anti-inflammatory effects of the stem barks from Albizia ferruginea (Mimosaceae) on chronic inflammation induced in rats. Int. J. Innov. Res. Med. Sci. 2018;3:2183\u20132195."}, {"Citation": "Meshram G.G., Kumar A., Rizvi W., Tripathi C.D., Khan R.A. Evaluation of the anti-inflammatory activity of the aqueous and ethanolic extracts of the leaves of Albizzia lebbeck in rats. J. Tradit. Complement. Med. 2015;6:172\u2013175. doi: 10.1016/j.jtcme.2014.11.038.", "ArticleIdList": ["10.1016/j.jtcme.2014.11.038", "PMC4833457", "27114941"]}, {"Citation": "Bakasatae N., Kunworarath N., Takahashi Yupanqui C., Voravuthikunchai S.P., Joycharat N. Bioactive components, antioxidant, and anti-inflammatory activities of the wood of Albizia myriophylla. Rev. Bras. Farmacogn. 2018;28:444\u2013450. doi: 10.1016/j.bjp.2018.05.010.", "ArticleIdList": ["10.1016/j.bjp.2018.05.010"]}, {"Citation": "Pu W.L., Zhang M.Y., Bai R.Y., Sun L.K., Li W.H., Yu Y.L., Zhang Y., Song L., Wang Z.X., Peng Y.F., et al. Anti-inflammatory effects of Rhodiola rosea L.: A review. Biomed. Pharmacother. 2020;121:109552. doi: 10.1016/j.biopha.2019.109552.", "ArticleIdList": ["10.1016/j.biopha.2019.109552", "31715370"]}, {"Citation": "Kosakowska O., B\u0105czek K., Przyby\u0142 J.L., Pi\u00f3ro-Jabrucka E., Czupa W., Synowiec A., Gniewosz M., Costa R., Mondello L., W\u0119glarz Z. Antioxidant and antibacterial activity of roseroot (Rhodiola rosea L.) dry extracts. Molecules. 2018;23:1767. doi: 10.3390/molecules23071767.", "ArticleIdList": ["10.3390/molecules23071767", "PMC6099734", "30022015"]}, {"Citation": "Lee Y., Jung J.C., Jang S., Kim J., Ali Z., Khan I.A., Oh S. Anti-inflammatory and neuroprotective effects of constituents isolated from Rhodiola rosea. Evid. Based Complement Alternat. Med. 2013;2013:514049.", "ArticleIdList": ["PMC3652169", "23690847"]}, {"Citation": "Zeinali M., Zirak M.R., Rezaee S.A., Karimi G., Hosseinzadeh H. Immunoregulatory and anti-inflammatory properties of Crocus sativus (Saffron) and its main active constituents: A review. Iran J. Basic Med. Sci. 2019;22:334\u2013344.", "ArticleIdList": ["PMC6535192", "31223464"]}, {"Citation": "Ebrahimi F., Sahebkar A., Aryaeian N., Pahlavani N., Fallah S., Moradi N., Abbasi D., Hosseini A.F. Effects of saffron supplementation on inflammation and metabolic responses in type 2 diabetic patients: A randomized, double-blind, placebo-controlled trial. Diabetes Metab. Syndr. Obes. 2019;12:2107\u20132115. doi: 10.2147/DMSO.S216666.", "ArticleIdList": ["10.2147/DMSO.S216666", "PMC6798815", "31686882"]}, {"Citation": "Ghobadi H., Abdollahi N., Madani H., Aslani M.R. Effect of crocin from saffron (Crocus sativus L.) supplementation on oxidant/antioxidant markers, exercise capacity, and pulmonary function tests in COPD patients: A randomized, double-blind, placebo-controlled trial. Front. Pharmacol. 2022;13:884710. doi: 10.3389/fphar.2022.884710.", "ArticleIdList": ["10.3389/fphar.2022.884710", "PMC9065288", "35517806"]}, {"Citation": "Bahraini M., Hosseini S.A., Cheraghian B., Shoushtari M.H. Effect of saffron on anti-inflammatory and oxidative stress in asthma. Int. J. Pharm. Phytopharm. Res. 2020;10:179\u2013184."}, {"Citation": "Poursamimi J., Shariati-Sarabi Z., Tavakkol-Afshari J., Mohajeri S.A., Mohammadi M. Crocus Sativus (Saffron): An immunoregulatory factor in the autoimmune and non-autoimmune diseases. Iran J. Allergy Asthma Immunol. 2020;19:27\u201342. doi: 10.18502/ijaai.v19i(s1.r1).2852.", "ArticleIdList": ["10.18502/ijaai.v19i(s1.r1).2852", "32534508"]}, {"Citation": "Olajide O.A. Inhibitory effects of St. John\u2019s Wort on inflammation: Ignored potential of a popular herb. J. Diet Suppl. 2009;6:28\u201332. doi: 10.1080/19390210802687247.", "ArticleIdList": ["10.1080/19390210802687247", "22435352"]}, {"Citation": "Tedeschi E., Menegazzi M., Margotto D., Suzuki H., F\u00f6rstermann U., Kleinert H. Anti-inflammatory actions of St. John\u2019s wort: Inhibition of human inducible nitric-oxide synthase expression by down-regulating signal transducer and activator of transcription-1alpha (STAT-1alpha) activation. J. Pharmacol. Exp. Ther. 2003;307:254\u2013261. doi: 10.1124/jpet.103.054460.", "ArticleIdList": ["10.1124/jpet.103.054460", "12954801"]}, {"Citation": "Koeberle A., Rossi A., Bauer J., Dehm F., Verotta L., Northoff H., Sautebin L., Werz O. Hyperforin, an anti-inflammatory constituent from St. John\u2019s Wort, inhibits microsomal prostaglandin E(2) synthase-1 and suppresses prostaglandin E(2) formation in vivo. Front. Pharmacol. 2011;2:7. doi: 10.3389/fphar.2011.00007.", "ArticleIdList": ["10.3389/fphar.2011.00007", "PMC3108608", "21687502"]}, {"Citation": "Bonaterra G.A., Schwendler A., H\u00fcther J., Schwarzbach H., Schwarz A., Kolb C., Abdel-Aziz H., Kinscherf R. Neurotrophic, cytoprotective, and anti-inflammatory effects of St. John\u2019s Wort extract on differentiated mouse hippocampal HT-22 neurons. Front. Pharmacol. 2018;8:955. doi: 10.3389/fphar.2017.00955.", "ArticleIdList": ["10.3389/fphar.2017.00955", "PMC5778116", "29403374"]}, {"Citation": "Brady K.T., Verduin M.L. Pharmacotherapy of comorbid mood, anxiety, and substance use disorders. Subst. Use Misuse. 2005;40:2043\u20132048. doi: 10.1080/10826080500294924.", "ArticleIdList": ["10.1080/10826080500294924", "16282091"]}, {"Citation": "Butterweck V., Schmidt M. St. John\u2019s wort: Role of active compounds for its mechanism of action and efficacy. Wien. Med. Wochenschr. 2007;157:356\u2013361. doi: 10.1007/s10354-007-0440-8.", "ArticleIdList": ["10.1007/s10354-007-0440-8", "17704987"]}, {"Citation": "Paulke A., N\u00f6ldner M., Schubert-Zsilavecz M., Wurglics M. St. John\u2019s wort flavonoids and their metabolites show antidepressant activity and accumulate in brain after multiple oral doses. Pharmazie. 2008;63:296\u2013302.", "ArticleIdList": ["18468390"]}, {"Citation": "Butterweck V. Mechanism of action of St. John\u2019s wort in depression: What is known? CNS Drugs. 2003;17:539\u2013562. doi: 10.2165/00023210-200317080-00001.", "ArticleIdList": ["10.2165/00023210-200317080-00001", "12775192"]}, {"Citation": "Di Carlo G., Borrelli F., Ernst E., Izzo A.A. St. John\u2019s wort: Prozac from the plant kingdom. Trends Pharmacol. Sci. 2001;22:292\u2013297. doi: 10.1016/S0165-6147(00)01716-8.", "ArticleIdList": ["10.1016/S0165-6147(00)01716-8", "11395157"]}, {"Citation": "Kholghi G., Arjmandi-Rad S., Zarrindast M.R., Vaseghi S. St. John\u2019s wort (Hypericum perforatum) and depression: What happens to the neurotransmitter systems? Naunyn. Schmiedebergs. Arch. Pharmacol. 2022;395:629\u2013642. doi: 10.1007/s00210-022-02229-z.", "ArticleIdList": ["10.1007/s00210-022-02229-z", "35294606"]}, {"Citation": "Avila-Sosa R., Nev\u00e1rez-Moorill\u00f3n G.V., Ochoa-Velasco C.E., Navarro-Cruz A.R., Hern\u00e1ndez-Carranza P., Cid-P\u00e9rez T.S. Detection of saffron\u2019s main bioactive compounds and their relationship with commercial quality. Foods. 2022;11:3245. doi: 10.3390/foods11203245.", "ArticleIdList": ["10.3390/foods11203245"]}, {"Citation": "Gohari A.R., Saeidnia S., Mahmoodabadi M.K. An overview on saffron, phytochemicals, and medicinal properties. Pharmacogn. Rev. 2013;7:61\u201366. doi: 10.4103/0973-7847.112850.", "ArticleIdList": ["10.4103/0973-7847.112850", "PMC3731881", "23922458"]}, {"Citation": "Siddiqui S.A., Ali Redha A., Snoeck E.R., Singh S., Simal-Gandara J., Ibrahim S.A., Jafari S.M. Anti-depressant properties of crocin molecules in saffron. Molecules. 2022;27:2076. doi: 10.3390/molecules27072076.", "ArticleIdList": ["10.3390/molecules27072076", "PMC9000812", "35408474"]}, {"Citation": "Shafiee M., Arekhi S., Omranzadeh A., Sahebkar A. Saffron in the treatment of depression, anxiety and other mental disorders: Current evidence and potential mechanisms of action. J. Affect. Disord. 2018;227:330\u2013337. doi: 10.1016/j.jad.2017.11.020.", "ArticleIdList": ["10.1016/j.jad.2017.11.020", "29136602"]}, {"Citation": "Maqbool Z., Arshad M.S., Ali A., Aziz A., Khalid W., Afzal M.F., Bangar S.P., Addi M., Hano C., Lorenzo J.M. Potential role of phytochemical extract from saffron in development of functional foods and protection of brain-related disorders. Oxid. Med. Cell. Longev. 2022;2022:6480590. doi: 10.1155/2022/6480590.", "ArticleIdList": ["10.1155/2022/6480590", "PMC9526642", "36193081"]}, {"Citation": "Petrisor G., Motelica L., Craciun L.N., Oprea O.C., Ficai D., Ficai A. Melissa officinalis: Composition, pharmacological effects and derived release systems-a review. Int. J. Mol. Sci. 2022;23:3591. doi: 10.3390/ijms23073591.", "ArticleIdList": ["10.3390/ijms23073591", "PMC8998931", "35408950"]}, {"Citation": "Sharifi-Rad J., Quispe C., Herrera-Bravo J., Akram M., Abbaass W., Semwal P., Painuli S., Konovalov D.A., Alfred M.A., Kumar N.V.A., et al. Phytochemical constituents, biological activities, and health-promoting effects of the Melissa officinalis. Oxid. Med. Cell. Longev. 2021;2021:6584693. doi: 10.1155/2021/6584693.", "ArticleIdList": ["10.1155/2021/6584693"]}, {"Citation": "Wake G., Court J., Pickering A., Lewis R., Wilkins R., Perry E. CNS acetylcholine receptor activity in European medicinal plants traditionally used to improve failing memory. J. Ethnopharmacol. 2000;69:105\u2013114. doi: 10.1016/S0378-8741(99)00113-0.", "ArticleIdList": ["10.1016/S0378-8741(99)00113-0", "10687867"]}, {"Citation": "Kenda M., Glava\u010d N.K., Nagy M., Dolenc M.S. Medicinal plants used for anxiety, depression, or stress treatment: An update. Molecules. 2022;27:6021. doi: 10.3390/molecules27186021.", "ArticleIdList": ["10.3390/molecules27186021", "PMC9500625", "36144755"]}, {"Citation": "Lin S.H., Chou M.L., Chen W.C., Lai Y.S., Lu K.H., Hao C.W., Sheen L.Y. A medicinal herb, Melissa officinalis L. ameliorates depressive-like behavior of rats in the forced swimming test via regulating the serotonergic neurotransmitter. J. Ethnopharmacol. 2015;175:266\u2013272. doi: 10.1016/j.jep.2015.09.018.", "ArticleIdList": ["10.1016/j.jep.2015.09.018", "26408043"]}, {"Citation": "Bia\u0142o\u0144 M., Krzy\u015bko-\u0141upicka T., Nowakowska-Bogdan E., Wieczorek P.P. Chemical composition of two different lavender essential oils and their effect on facial skin microbiota. Molecules. 2019;24:3270. doi: 10.3390/molecules24183270.", "ArticleIdList": ["10.3390/molecules24183270", "PMC6767019", "31500359"]}, {"Citation": "Prusinowska R., \u015amigielski K.B. Composition, biological properties and therapeutic effects of lavender. A review. Herba Pol. 2014;60:56\u201366. doi: 10.2478/hepo-2014-0010.", "ArticleIdList": ["10.2478/hepo-2014-0010"]}, {"Citation": "L\u00f3pez V., Nielsen B., Solas M., Ram\u00edrez M.J., J\u00e4ger A.K. Exploring pharmacological mechanisms of lavender (Lavandula angustifolia) essential oil on central nervous system targets. Front. Pharmacol. 2017;8:280. doi: 10.3389/fphar.2017.00280.", "ArticleIdList": ["10.3389/fphar.2017.00280", "PMC5437114", "28579958"]}, {"Citation": "Shamabadi A., Akhondzadeh S. Bioactive components for depression: Naringin, caffeine, probiotics, saffron and lavender may exert antidepressant effects through inflammation modulation. J. Iran Med. Counc. 2022;5:1\u20133. doi: 10.18502/jimc.v5i1.9562.", "ArticleIdList": ["10.18502/jimc.v5i1.9562"]}, {"Citation": "Schuwald A.M., N\u00f6ldner M., Wilmes T., Klugbauer N., Leuner K., M\u00fcller W.E. Lavender oil-potent anxiolytic properties via modulating voltage dependent calcium channels. PLoS ONE. 2013;8:e59998. doi: 10.1371/journal.pone.0059998.", "ArticleIdList": ["10.1371/journal.pone.0059998", "PMC3639265", "23637742"]}, {"Citation": "Adamczak A., Buchwald W., Gryszczy\u0144ska A. Biometric features and content of phenolic compounds of roseroot (Rhodiola rosea L.) Acta Soc. Bot. Pol. 2016;85:3500. doi: 10.5586/asbp.3500.", "ArticleIdList": ["10.5586/asbp.3500"]}, {"Citation": "Chiang H.M., Chen H.C., Wu C.S., Wu P.Y., Wen K.C. Rhodiola plants: Chemistry and biological activity. J. Food Drug Anal. 2015;23:359\u2013369. doi: 10.1016/j.jfda.2015.04.007.", "ArticleIdList": ["10.1016/j.jfda.2015.04.007", "PMC9351785", "28911692"]}, {"Citation": "Amsterdam J.D., Panossian A.G. Rhodiola rosea L. as a putative botanical antidepressant. Phytomedicine. 2016;23:770\u2013783. doi: 10.1016/j.phymed.2016.02.009.", "ArticleIdList": ["10.1016/j.phymed.2016.02.009", "27013349"]}, {"Citation": "Konstantinos F., Heun R. The effects of Rhodiola rosea supplementation on depression, anxiety and mood\u2014A systematic review. Glob. Psychiatry. 2020;3:72\u201382. doi: 10.2478/gp-2019-0022.", "ArticleIdList": ["10.2478/gp-2019-0022"]}, {"Citation": "Stojcheva E.I., Quintela J.C. The effectiveness of Rhodiola rosea L. preparations in alleviating various aspects of life-stress symptoms and stress-induced conditions-encouraging clinical evidence. Molecules. 2022;27:3902. doi: 10.3390/molecules27123902.", "ArticleIdList": ["10.3390/molecules27123902", "PMC9228580", "35745023"]}, {"Citation": "Fermino B.L., Milanez M.C., de Freitas G.B.L., da Silva W.C.F.N., Pereira R.P., da Rocha J.B.T., Bonini J.S. Ginkgo biloba L.: Phytochemical components and antioxidant activity. AJPP. 2015;9:950\u2013955."}, {"Citation": "Bai S., Zhang X., Chen Z., Wang W., Hu Q., Liang Z., Shen P., Gui S., Zeng L., Liu Z., et al. Insight into the metabolic mechanism of diterpene ginkgolides on antidepressant effects for attenuating behavioural deficits compared with venlafaxine. Sci. Rep. 2017;7:9591. doi: 10.1038/s41598-017-10391-1.", "ArticleIdList": ["10.1038/s41598-017-10391-1", "PMC5575021", "28852120"]}, {"Citation": "Fehske C.J., Leuner K., M\u00fcller W.E. Ginkgo biloba extract (EGb761) influences monoaminergic neurotransmission via inhibition of NE uptake, but not MAO activity after chronic treatment. Pharmacol. Res. 2009;60:68\u201373. doi: 10.1016/j.phrs.2009.02.012.", "ArticleIdList": ["10.1016/j.phrs.2009.02.012", "19427589"]}, {"Citation": "Sloley B.D., Urichuk L.J., Morley P., Durkin J., Shan J.J., Pang P.K., Coutts R.T. Identification of kaempferol as a monoamine oxidase inhibitor and potential neuroprotectant in extracts of Ginkgo biloba leaves. J. Pharm. Pharmacol. 2000;52:451\u2013459. doi: 10.1211/0022357001774075.", "ArticleIdList": ["10.1211/0022357001774075", "10813558"]}, {"Citation": "L\u00fc J.M., Yao Q., Chen C. Ginseng compounds: An update on their molecular mechanisms and medical applications. Curr. Vasc. Pharmacol. 2009;7:293\u2013302. doi: 10.2174/157016109788340767.", "ArticleIdList": ["10.2174/157016109788340767", "PMC2928028", "19601854"]}, {"Citation": "Ratan Z.A., Haidere M.F., Hong Y.H., Park S.H., Lee J.O., Lee J., Cho J.Y. Pharmacological potential of ginseng and its major component ginsenosides. J. Ginseng Res. 2021;45:199\u2013210. doi: 10.1016/j.jgr.2020.02.004.", "ArticleIdList": ["10.1016/j.jgr.2020.02.004", "PMC8020288", "33841000"]}, {"Citation": "Jin Y., Cui R., Zhao L., Fan J., Li B. Mechanisms of Panax ginseng action as an antidepressant. Cell Prolif. 2019;52:e12696. doi: 10.1111/cpr.12696.", "ArticleIdList": ["10.1111/cpr.12696", "PMC6869450", "31599060"]}, {"Citation": "Mu D., Ma Q. A review of antidepressant effects and mechanisms of three common herbal medicines: Panax ginseng, Bupleurum chinense, and Gastrodia elata. CNS Neurol. Disord. Drug Targets. 2022 doi: 10.2174/1871527322666221116164836. Online ahead of print.", "ArticleIdList": ["10.2174/1871527322666221116164836", "36397625"]}, {"Citation": "Hou W., Wang Y., Zheng P., Cui R. Effects of Ginseng on neurological disorders. Front. Cell. Neurosci. 2020;14:55. doi: 10.3389/fncel.2020.00055.", "ArticleIdList": ["10.3389/fncel.2020.00055", "PMC7099600", "32265659"]}, {"Citation": "Abolhassani M. Antiviral activity of borage (Echium amoenum) Arch. Med. Sci. 2010;6:366\u2013369. doi: 10.5114/aoms.2010.14256.", "ArticleIdList": ["10.5114/aoms.2010.14256", "PMC3282513", "22371772"]}, {"Citation": "Zannou O., Pashazadeh H., Ghellam M., Ibrahim S.A., Koca I. Extraction of anthocyanins from Borage (Echium amoenum) flowers using choline chloride and a glycerol-based, deep eutectic solvent: Optimization, antioxidant activity, and in vitro bioavailability. Molecules. 2021;27:134. doi: 10.3390/molecules27010134.", "ArticleIdList": ["10.3390/molecules27010134", "PMC8746641", "35011365"]}, {"Citation": "Nouri M., Farajdokht F., Torbati M., Ranjbar F., Hamedyazdan S., Araj-Khodaei M., Sadigh-Eteghad S. A close look at Echium amoenum processing, neuroactive components, and effects on neuropsychiatric disorders. Galen Med. J. 2019;8:e1559. doi: 10.31661/gmj.v8i0.1559.", "ArticleIdList": ["10.31661/gmj.v8i0.1559", "PMC8343809", "34466529"]}, {"Citation": "Abdol N., Setorki M. Evaluation of antidepressant, antianxiolytic, and antioxidant effects of Echium amoenum L. extract on social isolation stress of male mice. Iran Red Crescent Med. J. 2020;22:e97593. doi: 10.5812/ircmj.97593.", "ArticleIdList": ["10.5812/ircmj.97593"]}, {"Citation": "Jeyasri R., Muthuramalingam P., Suba V., Ramesh M., Chen J.T. Bacopa monnieri and their bioactive compounds inferred multi-target treatment strategy for neurological diseases: A cheminformatics and system pharmacology approach. Biomolecules. 2020;10:536. doi: 10.3390/biom10040536.", "ArticleIdList": ["10.3390/biom10040536", "PMC7225932", "32252235"]}, {"Citation": "Mathur D., Goyal K., Koul V., Anand A. The molecular links of re-emerging therapy: A review of evidence of Brahmi (Bacopa monniera) Front. Pharmacol. 2016;7:44. doi: 10.3389/fphar.2016.00044.", "ArticleIdList": ["10.3389/fphar.2016.00044", "PMC4778428", "26973531"]}, {"Citation": "Liu X., Liu F., Yue R., Li Y., Zhang J., Wang S., Zhang S., Wang R., Shan L., Zhang W. The antidepressant-like effect of bacopaside I: Possible involvement of the oxidative stress system and the noradrenergic system. Pharmacol. Biochem. Behav. 2013;110:224\u2013230. doi: 10.1016/j.pbb.2013.07.007.", "ArticleIdList": ["10.1016/j.pbb.2013.07.007", "23872136"]}, {"Citation": "Sekhar V.C., Viswanathan G., Baby S. Insights into the molecular aspects of neuroprotective Bacoside A and Bacopaside I. Curr. Neuropharmacol. 2019;17:438\u2013446. doi: 10.2174/1570159X16666180419123022.", "ArticleIdList": ["10.2174/1570159X16666180419123022", "PMC6520587", "29676230"]}, {"Citation": "Fatima U., Roy S., Ahmad S., Ali S., Elkady W.M., Khan I., Alsaffar R.M., Adnan M., Islam A., Hassan M.I. Pharmacological attributes of Bacopa monnieri extract: Current updates and clinical manifestation. Front. Nutr. 2022;9:972379. doi: 10.3389/fnut.2022.972379.", "ArticleIdList": ["10.3389/fnut.2022.972379", "PMC9436272", "36061899"]}, {"Citation": "Asgarirad H., Chabra A., Rahimnejad M., Zaghi Hosseinzadeh A., Davoodi A., Azadbakht M. Comparison of Albizia Julibressin and silver sulfadiazine in healing of second and third degree burns. World J. Plast. Surg. 2018;7:34\u201344.", "ArticleIdList": ["PMC5890364", "29651390"]}, {"Citation": "Mahasweta R., Yadav D.K., Kumar B., Kaur J., Patel A.K., Kumar N. A review on phytochemical and pharmacological studies of Albizia julibrissin: An ornamental plant. World J. Pharm. Res. 2016;5:598\u2013604."}, {"Citation": "Patro G., Kumar Bhattamisra S., Kumar Mohanty B. Effects of Mimosa pudica L. leaves extract on anxiety, depression and memory. Avicenna J. Phytomed. 2016;6:696\u2013710.", "ArticleIdList": ["PMC5206927", "28078250"]}, {"Citation": "Udyavar S., Kumar K.S., Rai M., Gopalakrishna H.N., Sowmya C.R. Evaluation of antidepressant activity of ethanolic extract of Mimosa pudica in swiss albino mice. Indian J. Pharm. Pharmacol. 2020;7:240\u2013244. doi: 10.18231/j.ijpp.2020.040.", "ArticleIdList": ["10.18231/j.ijpp.2020.040"]}, {"Citation": "Duarte-Filho L.A.M.S., Amariz I.A., Nishimura R.H.V., Massaranduba A.B.R., Menezes P.M.N., Damasceno T.A., Brys I., Rolim L.A., Silva F.S., Ribeiro L.A.A. \u03b2-carboline-independent antidepressant-like effect of the standardized extract of the barks of Mimosa tenuiflora (Willd) Poir. occurs via 5-HT2A/2C receptors in mice. J. Psychopharmacol. 2022;36:836\u2013848. doi: 10.1177/02698811221104050.", "ArticleIdList": ["10.1177/02698811221104050", "35723216"]}, {"Citation": "Pato\u010dka J., Jakl J., Struneck\u00e1 A. Expectations of biologically active compounds of the genus Magnolia in biomedicine. J. Appl. Biomed. 2006;4:171\u2013178. doi: 10.32725/jab.2006.019.", "ArticleIdList": ["10.32725/jab.2006.019"]}, {"Citation": "Lee Y.J., Lee Y.M., Lee C.K., Jung J.K., Han S.B., Hong J.T. Therapeutic applications of compounds in the Magnolia family. Pharmacol. Ther. 2011;130:157\u2013176. doi: 10.1016/j.pharmthera.2011.01.010.", "ArticleIdList": ["10.1016/j.pharmthera.2011.01.010", "21277893"]}, {"Citation": "Yi L.T., Xu Q., Li Y.C., Yang L., Kong L.D. Antidepressant-like synergism of extracts from magnolia bark and ginger rhizome alone and in combination in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2009;33:616\u2013624. doi: 10.1016/j.pnpbp.2009.03.001.", "ArticleIdList": ["10.1016/j.pnpbp.2009.03.001", "19285110"]}, {"Citation": "Zhang B., Wang P.P., Hu K.L., Li L.N., Yu X., Lu Y., Chang H.S. Antidepressant-like effect and mechanism of action of honokiol on the mouse lipopolysaccharide (LPS) depression model. Molecules. 2019;24:2035. doi: 10.3390/molecules24112035.", "ArticleIdList": ["10.3390/molecules24112035", "PMC6600641", "31141940"]}, {"Citation": "Fan X.X., Sun W.Y., Li Y., Tang Q., Li L.N., Yu X., Wang S.Y., Fan A.R., Xu X.Q., Chang H.S. Honokiol improves depression-like behaviors in rats by HIF-1\u03b1-VEGF signaling pathway activation. Front. Pharmacol. 2022;13:968124. doi: 10.3389/fphar.2022.968124.", "ArticleIdList": ["10.3389/fphar.2022.968124", "PMC9453876", "36091747"]}, {"Citation": "Tenny S., Varacallo M.  StatPearls. StatPearls Publishing; Treasure Island, FL, USA: 2022.  [(accessed on 9 December 2022)]. Evidence Based Medicine. Available online:  https://www.ncbi.nlm.nih.gov/books/NBK470182/"}, {"Citation": "Szajewska H. Evidence-Based Medicine and clinical research: Both are needed, neither is perfect. Ann. Nutr. Metab. 2018;72:13\u201323. doi: 10.1159/000487375.", "ArticleIdList": ["10.1159/000487375", "29631266"]}, {"Citation": "Murad M.H., Asi N., Alsawas M., Alahdab F. New evidence pyramid. Evid. Based Med. 2016;21:125\u2013127. doi: 10.1136/ebmed-2016-110401.", "ArticleIdList": ["10.1136/ebmed-2016-110401", "PMC4975798", "27339128"]}, {"Citation": "Cui Y.H., Zheng Y. A meta-analysis on the efficacy and safety of St. John\u2019s wort extract in depression therapy in comparison with selective serotonin reuptake inhibitors in adults. Neuropsychiatr. Dis. Treat. 2016;12:1715\u20131723.", "ArticleIdList": ["PMC4946846", "27468236"]}, {"Citation": "Apaydin E.A., Maher A.R., Shanman R., Booth M.S., Miles J.N., Sorbero M.E., Hempel S. A systematic review of St. John\u2019s wort for major depressive disorder. Syst. Rev. 2016;5:148. doi: 10.1186/s13643-016-0325-2.", "ArticleIdList": ["10.1186/s13643-016-0325-2", "PMC5010734", "27589952"]}, {"Citation": "Ng Q.X., Venkatanarayanan N., Ho C.Y. Clinical use of Hypericum perforatum (St. John\u2019s wort) in depression: A meta-analysis. J. Affect Disord. 2017;210:211\u2013221. doi: 10.1016/j.jad.2016.12.048.", "ArticleIdList": ["10.1016/j.jad.2016.12.048", "28064110"]}, {"Citation": "Hausenblas H.A., Heekin K., Mutchie H.L., Anton S. A systematic review of randomized controlled trials examining the effectiveness of saffron (Crocus sativus L.) on psychological and behavioral outcomes. J. Integr. Med. 2015;13:231\u2013240. doi: 10.1016/S2095-4964(15)60176-5.", "ArticleIdList": ["10.1016/S2095-4964(15)60176-5", "PMC5747362", "26165367"]}, {"Citation": "Hausenblas H.A., Saha D., Dubyak P.J., Anton S.D. Saffron (Crocus sativus L.) and major depressive disorder: A meta-analysis of randomized clinical trials. J. Integr. Med. 2013;11:377\u2013383. doi: 10.3736/jintegrmed2013056.", "ArticleIdList": ["10.3736/jintegrmed2013056", "PMC4643654", "24299602"]}, {"Citation": "Jackson P.A., Forster J., Khan J., Pouchieu C., Dubreuil S., Gaudout D., Moras B., Pourtau L., Joffre F., Vaysse C., et al. Effects of saffron extract supplementation on mood, well-being, and response to a psychosocial stressor in healthy adults: A randomized, double-blind, parallel group, clinical trial. Front. Nutr. 2021;7:606124. doi: 10.3389/fnut.2020.606124.", "ArticleIdList": ["10.3389/fnut.2020.606124", "PMC7882499", "33598475"]}, {"Citation": "Akhondzadeh S., Mostafavi S.A., Keshavarz S.A., Mohammadi M.R., Hosseini S., Eshraghian M.R. A placebo controlled randomized clinical trial of Crocus sativus L. (saffron) on depression and food craving among overweight women with mild to moderate depression. J. Clin. Pharm. Ther. 2020;45:134\u2013143. doi: 10.1111/jcpt.13040.", "ArticleIdList": ["10.1111/jcpt.13040", "31602695"]}, {"Citation": "Ghazizadeh J., Sadigh-Eteghad S., Marx W., Fakhari A., Hamedeyazdan S., Torbati M., Taheri-Tarighi S., Araj-Khodaei M., Mirghafourvand M. The effects of lemon balm (Melissa officinalis L.) on depression and anxiety in clinical trials: A systematic review and meta-analysis. Phytother. Res. 2021;35:6690\u20136705. doi: 10.1002/ptr.7252.", "ArticleIdList": ["10.1002/ptr.7252", "34449930"]}, {"Citation": "Haybar H., Javid A.Z., Haghighizadeh M.H., Valizadeh E., Mohaghegh S.M., Mohammadzadeh A. The effects of Melissa officinalis supplementation on depression, anxiety, stress, and sleep disorder in patients with chronic stable angina. Clin. Nutr. ESPEN. 2018;26:47\u201352. doi: 10.1016/j.clnesp.2018.04.015.", "ArticleIdList": ["10.1016/j.clnesp.2018.04.015", "29908682"]}, {"Citation": "Heidari M., Soltanpour A., Naseri M., Kazemnezhad A. The effect of Lemon Balm (Melissa officinalis) on depression in patients after coronary artery bypass graft. Iran J. Cardiovasc. Nurs. 2015;4:43\u201346."}, {"Citation": "Firoozeei T.S., Feizi A., Rezaeizadeh H., Zargaran A., Roohafza H.R., Karimi M. The antidepressant effects of lavender (Lavandula angustifolia Mill.): A systematic review and meta-analysis of randomized controlled clinical trials. Complement. Ther. Med. 2021;59:102679. doi: 10.1016/j.ctim.2021.102679.", "ArticleIdList": ["10.1016/j.ctim.2021.102679", "33549687"]}, {"Citation": "Nategh M., Reza H.M., Abbas E., Reza N., Zahra M., Bahman A. Lavender aromatherapy on anxiety and depression in patients with Acute Coronary Syndrome: A single-blind randomized clinical trial. Front. Nurs. 2022;9:233\u2013239. doi: 10.2478/fon-2022-0022.", "ArticleIdList": ["10.2478/fon-2022-0022"]}, {"Citation": "Tayebi A., Kasra Dehkordi A., Ebadi A., Sahraei H., Einollahi B. The Effect of aromatherapy with Lavender essential oil on depression, anxiety and stress in hemodialysis patients: A clinical trial. Evid. Based Care J. 2015;5:65\u201374."}, {"Citation": "Jokar M., Delam H., Bakhtiari S., Paki S., Askari A., Bazrafshan M.R., Shokrpour N. The effects of inhalation Lavender aromatherapy on postmenopausal women\u2019s depression and anxiety: A randomized clinical trial. JNP. 2020;16:617\u2013622. doi: 10.1016/j.nurpra.2020.04.027.", "ArticleIdList": ["10.1016/j.nurpra.2020.04.027"]}, {"Citation": "Mao J.J., Xie S.X., Zee J., Soeller I., Li Q.S., Rockwell K., Amsterdam J.D. Rhodiola rosea versus sertraline for major depressive disorder: A randomized placebo-controlled trial. Phytomedicine. 2015;22:394\u2013399. doi: 10.1016/j.phymed.2015.01.010.", "ArticleIdList": ["10.1016/j.phymed.2015.01.010", "PMC4385215", "25837277"]}, {"Citation": "Liang Z.H., Jia Y.B., Wang M.L., Li Z.R., Li M., Yun Y.L., Zhu R.X. Efficacy of Ginkgo Biloba extract as augmentation of venlafaxine in treating post-stroke depression. Neuropsychiatr. Dis. Treat. 2019;15:2551\u20132557. doi: 10.2147/NDT.S215191.", "ArticleIdList": ["10.2147/NDT.S215191", "PMC6731991", "31564880"]}, {"Citation": "Dai C.X., Hu C.C., Shang Y.S., Xie J. Role of Ginkgo biloba extract as an adjunctive treatment of elderly patients with depression and on the expression of serum S100B. Medicine. 2018;97:e12421. doi: 10.1097/MD.0000000000012421.", "ArticleIdList": ["10.1097/MD.0000000000012421", "PMC6181482", "30278520"]}, {"Citation": "Jeong H.G., Ko Y.H., Oh S.Y., Han C., Kim T., Joe S.H. Effect of Korean Red Ginseng as an adjuvant treatment for women with residual symptoms of major depression. Asia Pac. Psychiatry. 2015;7:330\u2013366. doi: 10.1111/appy.12169.", "ArticleIdList": ["10.1111/appy.12169", "25504813"]}, {"Citation": "Lee K.H., Bahk W.M., Lee S.J., Pae C.U. Effectiveness and tolerability of Korean Red Ginseng augmentation in major depressive disorder patients with difficult-to-treat in routine practice. Clin. Psychopharmacol. Neurosci. 2020;18:621\u2013626. doi: 10.9758/cpn.2020.18.4.621.", "ArticleIdList": ["10.9758/cpn.2020.18.4.621", "PMC7609220", "33124595"]}, {"Citation": "Sayyah M., Sayyah M., Kamalinejad M. A preliminary randomized double blind clinical trial on the efficacy of aqueous extract of Echium amoenum in the treatment of mild to moderate major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2006;30:166\u2013169. doi: 10.1016/j.pnpbp.2005.10.005.", "ArticleIdList": ["10.1016/j.pnpbp.2005.10.005", "16309809"]}, {"Citation": "Najafabady M.T., Baghbadoranee P.Y., Moghimipour E., Haghighizadeh M.H., Boostani H. Comparison the effect of Echium amoenum extract with fluoxetine on depression in menopausal women. A double-blind randomized controlled trial. Asian J. Pharm. 2019;13:271\u2013275."}, {"Citation": "Bargard M.S., Assadi S., Amini H., Saiiah M., Akhondzadeh S., Kamalinejad M. Efficacy of aqueous extract of Echium amoenum L. in the treatment of mild to moderate major depressive disorder: A randomized double blind clinical trial. J. Med. Plants. 2004;3:61\u201368."}, {"Citation": "Shetty S.K., Rao P.N., U S., Raj A., Ks S., Sv S. The effect of Brahmi (Bacopa monnieri (L.) Pennell) on depression, anxiety and stress during Covid-19. Eur. J. Integr. Med. 2021;48:101898. doi: 10.1016/j.eujim.2021.101898.", "ArticleIdList": ["10.1016/j.eujim.2021.101898"]}, {"Citation": "Calabrese C., Gregory W.L., Leo M., Kraemer D., Bone K., Oken B. Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: A randomized, double-blind, placebo-controlled trial. J. Altern. Complement. Med. 2008;14:707\u2013713. doi: 10.1089/acm.2008.0018.", "ArticleIdList": ["10.1089/acm.2008.0018", "PMC3153866", "18611150"]}, {"Citation": "Shi X., Jiang C., Zhao X., Zhang Y.Q. Study on the Effects of Albizia julibrissin flower on cognitive function and plasma 5-HT, NE and DA in patients with depression: A randomized parallel controlled multicenter clinical trial. J. Pract. Tradit. Chin. Intern. Med. 2013;27:18\u201320."}, {"Citation": "Xue L., Zhang J., Shen H., Ai L., Wu R. A randomized controlled pilot study of the effectiveness of magnolia tea on alleviating depression in postnatal women. Food Sci. Nutr. 2020;8:1554\u20131561. doi: 10.1002/fsn3.1442.", "ArticleIdList": ["10.1002/fsn3.1442", "PMC7063344", "32180964"]}, {"Citation": "Panossian A.G., Efferth T., Shikov A.N., Pozharitskaya O.N., Kuchta K., Mukherjee P.K., Banerjee S., Heinrich M., Wu W., Guo D.A., et al. Evolution of the adaptogenic concept from traditional use to medical systems: Pharmacology of stress- and aging-related diseases. Med. Res. Rev. 2021;41:630\u2013703. doi: 10.1002/med.21743.", "ArticleIdList": ["10.1002/med.21743", "PMC7756641", "33103257"]}, {"Citation": "Panossian A., Efferth T. Network pharmacology of adaptogens in the assessment of their pleiotropic therapeutic activity. Pharmaceuticals. 2022;15:1051. doi: 10.3390/ph15091051.", "ArticleIdList": ["10.3390/ph15091051", "PMC9504187", "36145272"]}, {"Citation": "Jawaid T., Gupta R., Siddiqui Z.A. A review on herbal plants showing antidepressant activity. IJPSR. 2011;2:3051\u20133060."}, {"Citation": "Rabiei Z., Rabiei S. A review on antidepressant effect of medicinal plants. Bangladesh J. Pharmacol. 2017;12:1\u201311. doi: 10.3329/bjp.v12i1.29184.", "ArticleIdList": ["10.3329/bjp.v12i1.29184"]}, {"Citation": "Taboada T., Alvarenga N.L., Galeano A.K., Arr\u00faa W.J., Campuzano-Bublitz M.A., Kennedy M.L. In vivo antidepressant-like effect assessment of two Aloysia species in mice and LCMS chemical characterization of ethanol extract. Molecules. 2022;27:7828. doi: 10.3390/molecules27227828.", "ArticleIdList": ["10.3390/molecules27227828", "PMC9693556", "36431928"]}, {"Citation": "Wang J., Hu D., Hou J., Li S., Wang W., Li J., Bai J. Ethyl acetate fraction of Hemerocallis citrina Baroni decreases tert-butyl hydroperoxide-induced oxidative stress damage in BRL-3A cells. Oxid. Med. Cell. Longev. 2018;2018:1526125. doi: 10.1155/2018/1526125.", "ArticleIdList": ["10.1155/2018/1526125", "PMC6250011", "30538798"]}, {"Citation": "Matraszek-Gawron R., Chwil M., Terlecka P., Skoczylas M.M. Recent studies on anti-depressant bioactive substances in selected species from the genera Hemerocallis and Gladiolus: A systematic review. Pharmaceuticals. 2019;12:172. doi: 10.3390/ph12040172.", "ArticleIdList": ["10.3390/ph12040172", "PMC6958339", "31775329"]}, {"Citation": "Odhiambo J.A., Siboe G.M., Lukhoba C.W., Dossaji S.F. Antifungal activity of crude extracts of Gladiolus dalenii van geel (iridaceae) Afr. J. Tradit. Complement. Altern. Med. 2009;7:53\u201358. doi: 10.4314/ajtcam.v7i1.57254.", "ArticleIdList": ["10.4314/ajtcam.v7i1.57254", "PMC3005389", "21304613"]}, {"Citation": "Agarwa P., Sharma B., Fatima A., Jain S.K. An update on Ayurvedic herb Convolvulus pluricaulis Choisy. Asian Pac. J. Trop. Biomed. 2014;4:245\u2013252. doi: 10.1016/S2221-1691(14)60240-9.", "ArticleIdList": ["10.1016/S2221-1691(14)60240-9", "PMC3868798", "25182446"]}, {"Citation": "Sharma R., Singla R.K., Banerjee S., Sinha B., Shen B., Sharma R. Role of Shankhpushpi (Convolvulus pluricaulis) in neurological disorders: An umbrella review covering evidence from ethnopharmacology to clinical studies. Neurosci. Biobehav. Rev. 2022;140:104795. doi: 10.1016/j.neubiorev.2022.104795.", "ArticleIdList": ["10.1016/j.neubiorev.2022.104795", "35878793"]}, {"Citation": "Moragrega I., R\u00edos J.L. Medicinal plants in the treatment of depression: Evidence from preclinical studies. Planta Med. 2021;87:656\u2013685. doi: 10.1055/a-1338-1011.", "ArticleIdList": ["10.1055/a-1338-1011", "33434941"]}, {"Citation": "Moragrega I., R\u00edos J.L. Medicinal plants in the treatment of depression. II: Evidence from clinical trials. Planta Med. 2022;88:1092\u20131110. doi: 10.1055/a-1517-6882.", "ArticleIdList": ["10.1055/a-1517-6882", "34157753"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "12", "Day": "29"}, {"Year": "2023", "Month": "2", "Day": "23"}, {"Year": "2023", "Month": "2", "Day": "25"}, {"Year": "2023", "Month": "3", "Day": "11", "Hour": "1", "Minute": "18"}, {"Year": "2023", "Month": "3", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "3", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "3", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["36902200", "PMC10003400", "10.3390/ijms24054772", "ijms24054772"]}}], "PubmedBookArticle": []}